C12N 2720/12134
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2720/12134 (Use of virus or viral component as vaccine) appears on 21 US grants and 25 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 25
- Assignees
- 26
- Inventors
- 56
- Latest grant
- 4 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 1 | 5 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 0 |
| 2016 | 2 | 2 |
| 2017 | 1 | 2 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 2 | 1 |
| 2021 | 3 | 3 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Plant-produced chimaeric orbivirus VLPs4 Feb 2025US 12,215,328 B2Csir
- Mammal-specific growth-defective arbovirus24 Sep 2024US 12,098,393 B2TenGen Biomedical Company
- Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vaccine7 Feb 2023US 11,571,471 B2Bavarian Nordic A/S
- Plant-produced chimaeric Orbivirus VLPs6 Jul 2021US 11,053,509 B2Csir
- Epizootic hemorrhagic disease vaccine5 Jan 2021US 10,881,722 B2Kansas State University Research Foundation
- Plant-produced chimaeric orbivirus vlps19 Jun 2025US 2025/0197874 A1Csir
- Plant-produced chimaeric orbivirus vlps16 Dec 2021US 2021/0388366 A1Csir
- Mammal-specific Growth-defective Arbovirus22 Jul 2021US 2021/0222132 A1TenGen Biomedical Company
- Recombinant Modified Vaccinia Virus Ankara (MVA) Equine Encephalitis Virus Vaccine8 Jul 2021US 2021/0205439 A1Bavarian Nordic A/S
- Epizootic hemorrhagic disease vaccine16 Jan 2020US 2020/0016259 A1Kansas State University Research Foundation
Most cited
By later US patents
- Preparation of inactivated viral vaccines92US 4,693,981 AAdvanced Genetics Research Institute · 1987
- Preparation of inactivated viral vaccines49US 5,106,619 ADiamond Scientific Co. · 1992
- Psoralen inactivated double-stranded RNA viral vaccines23US 4,545,987 AAdvanced Genetics Research Institute · 1985
- Vaccine for bluetongue disease employing platinum compounds3US 4,645,666 AThe Regents of the University of California · 1987
- Recombinant vaccine against bluetongue virus2US 7,862,821 B2Merial Limited · 2011